|
2026 Journal Article Janus kinase inhibitors for acute severe ulcerative colitis: comparing upadacitinib to tofacitinib and rescue to sequential salvage therapyGilmore, R., Fernandes, R., Goetz, N., Chin, S., Con, D., De Cruz, P., Demase, K., Sparrow, M. P., Lucas, S., Garg, M., Tuttle, Z., Clark, N., Tassone, D., Ding, N., Loebenstein, M., Nguyen, A., Moore, G. T., Thin, L., MacFarlane, K., Lynch, K. D., Subhaharan, D., Mohsen, W., Haig, A., Day, M., White, L., Baker, J., Venugopal, K., Tandon, B., Bryant, R. V. ... An, Y. K. (2026). Janus kinase inhibitors for acute severe ulcerative colitis: comparing upadacitinib to tofacitinib and rescue to sequential salvage therapy. Clinical Gastroenterology and Hepatology. doi: 10.1016/j.cgh.2026.09.017 |
|
2026 Journal Article Letter: Acute Severe Ulcerative Colitis in the Advanced Therapy Era: Is Lowering the CRP Threshold Enough? Authors' ReplyEtchegaray, Amirah, Radford‐Smith, Graham, Walker, Gareth, Croft, Anthony and all co‐authors (2026). Letter: Acute Severe Ulcerative Colitis in the Advanced Therapy Era: Is Lowering the CRP Threshold Enough? Authors' Reply. Alimentary Pharmacology & Therapeutics apt.70962. doi: 10.1111/apt.70962 |
|
2026 Journal Article Editorial on: ‘Lowering the C‐Reactive Protein Threshold Improves Risk Stratification in Acute Ulcerative Colitis: A Propensity‐Matched Analysis’. Authors' ReplyEtchegaray, Amirah, Goetz, Naeman, Hanigan, Katherine, Phillips, Jennifer, Kumar, Rina, Tambakis, George, Radford‐Smith, Graham, Walker, Gareth and Croft, Anthony (2026). Editorial on: ‘Lowering the C‐Reactive Protein Threshold Improves Risk Stratification in Acute Ulcerative Colitis: A Propensity‐Matched Analysis’. Authors' Reply. Alimentary Pharmacology & Therapeutics, 64 (7), 1007-1008. doi: 10.1111/apt.70885 |
|
2026 Journal Article Lowering the C‐Reactive Protein ( <scp>CRP</scp> ) Threshold Improves Risk Stratification in Acute Ulcerative Colitis: A Propensity‐Matched AnalysisEtchegaray, Amirah, Goetz, Naeman, Hanigan, Katherine, Phillips, Jennifer, Kumar, Rina, Tambakis, George, Radford‐Smith, Graham, Walker, Gareth and Croft, Anthony (2026). Lowering the C‐Reactive Protein ( CRP ) Threshold Improves Risk Stratification in Acute Ulcerative Colitis: A Propensity‐Matched Analysis. Alimentary Pharmacology & Therapeutics, 64 (7) apt.70825, 985-1000. doi: 10.1111/apt.70825 |
|
2025 Journal Article Endosonographically confirmed Type III Choledochal Cyst Managed with Endoscopic Needle Knife DivisionEtchegaray, Amirah, Mudaliar, Sanjivan and Devereaux, Benedict (2025). Endosonographically confirmed Type III Choledochal Cyst Managed with Endoscopic Needle Knife Division. VideoGIE, 10 (8), 406-409. doi: 10.1016/j.vgie.2025.03.035 |
|
2025 Journal Article Ruptured hepatocellular carcinoma secondary to undiagnosed Hepatitis B in a young male Papua New Guinean patientBrough, David, Dahlenburg, Dominique, McNamara, Adam, Etchegaray, Amirah, Olive, Emily, Cavallucci, David, Bryant, Richard, Davis, Samuel, Foong, Samuel, Leggett, Barbara and O'Rourke, Nicholas (2025). Ruptured hepatocellular carcinoma secondary to undiagnosed Hepatitis B in a young male Papua New Guinean patient. HPB Cancer International, 3 (1), 1-5. doi: 10.64292/hpbci.160 |
|
2025 Journal Article Upadacitinib and vedolizumab combination therapy for the management of refractory ulcerative colitis and Crohn’s diseaseGilmore, Robert, Murali, Amrutha, Etchegaray, Amirah, Swe, Ei, An, Yoon-Kyo and Begun, Jakob (2025). Upadacitinib and vedolizumab combination therapy for the management of refractory ulcerative colitis and Crohn’s disease. Intestinal Research, 23 (4), 475-482. doi: 10.5217/ir.2024.00174 |
|
2025 Journal Article The durability of anti-TNF therapy for Crohn’s Disease is higher in anti-TNF naïve patients and increases with proactive therapeutic drug monitoringGilmore, Robert, Fernandes, Richard, Schildkraut, Tamar, Joshi, Riddhi, Lin, Lyman, Vorgin, Sara, Etchegaray, Amirah, Shanmuga Anandan, Aathavan, Tambakis, George, Loebenstein, Moshe, An, Yoon-Kyo, Begun, Jakob and Wright, Emily K (2025). The durability of anti-TNF therapy for Crohn’s Disease is higher in anti-TNF naïve patients and increases with proactive therapeutic drug monitoring. Crohn's and Colitis 360, 7 (2) otaf028, 1-9. doi: 10.1093/crocol/otaf028 |
|
2025 Journal Article Safety, efficacy and post-endoscopic retrograde cholangiopancreatography survival in nonagenarians: a retrospective cohort studyEtchegaray, Amirah, Mudaliar, Sanjivan, Ryan, Kimberley, Hay, Karen, Hwang, Jason, Devereaux, Benedict, Appleyard, Mark and Grimpen, Florian (2025). Safety, efficacy and post-endoscopic retrograde cholangiopancreatography survival in nonagenarians: a retrospective cohort study. Internal Medicine Journal, 55 (3), 435-443. doi: 10.1111/imj.16652 |
|
2025 Journal Article Sequential rescue therapy with JAK inhibitors in corticosteroid and infliximab-refractory acute severe ulcerative colitis: a case seriesEtchegaray, Amirah, Tambakis, George, Kumar, Rina, Croft, Anthony, Radford-Smith, Graham and Walker, Gareth J. (2025). Sequential rescue therapy with JAK inhibitors in corticosteroid and infliximab-refractory acute severe ulcerative colitis: a case series. Therapeutic Advances in Gastroenterology, 18 17562848251323511, 1-14. doi: 10.1177/17562848251323511 |
